Mankind Pharma: From Volume Recovery to a Chronic and Specialty-led Growth Model
Moneylife Digital Team 14 August 2026
Mankind Pharma (Mankind) has built its position through a distinctive grassroots strategy, initially targeting underserved rural communities with quality medications before expanding to tier-1...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Privi Speciality Chemicals: Strong Q1 Growth Keeps ₹5,000-Crore Vision on Track
Moneylife Digital Team 12 August 2026
Privi Speciality Chemicals (Privi) has established itself as a fully-integrated manufacturer and exporter of aroma chemicals, over more than three decades. The company serves 40+ countries, supplying to major international fragrance...
IPO Review: Behari Lal Engineering Limited
Moneylife Digital Team 12 August 2026
Behari Lal Engineering Limited (BLEL) is an integrated manufacturer of alloy steel products, specialised metal rolls and engineering castings, serving customers across the steel, mining, energy, automotive, cement, sugar and defence...
IPO Review: Shiprocket Ltd
Moneylife Digital Team 11 August 2026
Shiprocket Limited (Shiprocket), incorporated in 2011 and based in Gurugram, is an end-to-end, technology-driven e-commerce enablement platform serving micro, small and medium enterprises (MSMEs), direct-to-consumer (D2C) brands and...
Anthem Biosciences: Weak Q1 Reflects Delivery Timing, Order-book Remains Strong
Moneylife Digital Team 11 August 2026
The global contract research, development and manufacturing organisation (CRDMO) industry was valued at approximately US$213bn (billion) in 2024 and is expected to reach US$330bn by 2029, implying a compound annual growth rate (CAGR)...
Free Helpline
Legal Credit
Feedback